Abstract
Metastasis to the regional lymph nodes through the lymphatic vessels is a common step in the progression of cancer and an important prognostic factor in many types of cancer. Recent evidence suggests that VEGF-C promotes lymphangiogenesis, and that tumor lymphangiogenesis in turn promotes lymphatic metastasis. We have studied the role of LVD in breast cancer, and examined whether LVD is associated with lymph node metastasis, VEGF-C expression, or prognosis. In addition, we examined whether VEGF-C mRNA transcript levels were associated with lymph node metastasis and LVD. We began by investigating the lymphatics in primary human breast carcinoma with long-term follow-up (113 cases of invasive ductal and other breast cancers) by quantitative immunohistochemical staining for podoplanin. We then analyzed the relationship between LVD and lymph node status as well as VEGF-C immunoreactivity and other established clinicopathological parameters. The relationship between LVD and prognosis was also studied. VEGF-C mRNA transcript levels were examined by quantitative real-time RT-PCR, in 55 invasive ductal breast carcinomas. This was followed by an analysis of the relationship between VEGF-C mRNA transcript levels and lymph node metastasis as well as LVD. Mean LVD of ‘hot spots’ was 10.2 ± 7.4/each case. LVD was significantly correlated with lymph node metastasis (p < 0.0001), VEGF-C immunoreactivity (p = 0.0084), and podoplanin positive lymphatic invasion (p < 0.0001). Survival curves determined by the Kaplan–Meier method and univariate analysis demonstrated that high LVD was associated with both worse disease free survival (p = 0.0033) and overall survival (p = 0.0391). VEGF-C mRNA transcript levels were also correlated with lymph node metastasis (p = 0.0074) and LVD (p = 0.0409). Increased LVD was correlated with lymph node metastasis and VEGF-C expression. High LVD may be a significant unfavorable prognostic factor for long-term survival in breast cancer.
Similar content being viewed by others
Abbreviations
- DFS:
-
disease-free survival
- ER:
-
estrogen receptor
- FVD:
-
Flt-4 positive vessel density
- GAPDH:
-
glyceraldehydes 3-phosphate dehydrogenase
- LVD:
-
podoplanin positive lymph vessel density
- LVI:
-
podoplanin positive lymph vessel invasion
- OS:
-
overall survival
- PCR:
-
polymerase chain reaction
- PgR:
-
progesterone receptor
- RT:
-
reverse transcription
- VEGF:
-
vascular endothelial growth factor
- VEGFR:
-
VEGF receptor
References
B Fisher M Bauer DL Wickerham CK Redmond ER Fisher AB Cruz R Foster B Gardner H Lerner R Margolese et al. (1983) ArticleTitleRelation of number of positive axillary nodes to the prognosis of patients with primary breast cancer An NSABP update. Cancer 52 1551–1557 Occurrence Handle1:STN:280:DyaL2c%2FgtFyhtQ%3D%3D
T Karpanen M Egeblad MJ Karkkainen H Kubo S Yla-Herttuala M Jaattela K Alitalo (2001) ArticleTitleVascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth Cancer Res 61 1786–1790 Occurrence Handle1:CAS:528:DC%2BD3MXit1OhtbY%3D Occurrence Handle11280723
SJ Mandriota L Jussila M Jeltsch A Compagni D Baetens R Prevo S Banerji J Huarte R Montesano DG Jackson L Orci K Alitalo G Christofori MS Pepper (2001) ArticleTitleVascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis Embo J 20 672–682 Occurrence Handle10.1093/emboj/20.4.672 Occurrence Handle1:CAS:528:DC%2BD3MXhsVyhtrw%3D Occurrence Handle11179212
SA Stacker C Caesar ME Baldwin GE Thornton RA Williams R Prevo DG Jackson S Nishikawa H Kubo MG Achen (2001) ArticleTitleVEGF-D promotes the metastatic spread of tumor cells via the lymphatics Nat Med 7 186–191 Occurrence Handle10.1038/84635 Occurrence Handle1:CAS:528:DC%2BD3MXhtVylu74%3D Occurrence Handle11175849
M Skobe T Hawighorst DG Jackson R Prevo L Janes P Velasco L Riccardi K Alitalo K Claffey M Detmar (2001) ArticleTitleInduction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nat Med 7 192–198 Occurrence Handle10.1038/84643 Occurrence Handle1:CAS:528:DC%2BD3MXhtVylu7s%3D Occurrence Handle11175850
S Breiteneder-Geleff K Matsui A Soleiman P Meraner H Poczewski R Kalt G Schaffner D Kerjaschki (1997) ArticleTitlePodoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis Am J Pathol 151 1141–1152 Occurrence Handle1:CAS:528:DyaK2sXmvFGmu7s%3D Occurrence Handle9327748
S Breiteneder-Geleff A Soleiman H Kowalski R Horvat G Amann E Kriehuber K Diem W Weninger E Tschachler K Alitalo D Kerjaschki (1999) ArticleTitleAngiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium Am J Pathol 154 385–394 Occurrence Handle1:STN:280:DyaK1M7kvFKnsQ%3D%3D Occurrence Handle10027397
P Birner M Schindl A Obermair C Plank G Breitenecker H Kowalski G Oberhuber (2000) ArticleTitleLymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis Anticancer Res 20 2981–2985 Occurrence Handle1:STN:280:DC%2BD3crhtVahsA%3D%3D Occurrence Handle11062711
P Birner A Obermair M Schindl H Kowalski G Breitenecker G Oberhuber (2001) ArticleTitleSelective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer Clin Cancer Res 7 93–97 Occurrence Handle1:STN:280:DC%2BD3M7lsFehtA%3D%3D Occurrence Handle11205924
P Birner M Schindl A Obermair G Breitenecker H Kowalski G Oberhuber (2001) ArticleTitleLymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer Int J Cancer 95 29–33 Occurrence Handle10.1002/1097-0215(20010120)95:1<29::AID-IJC1005>3.0.CO;2-W Occurrence Handle1:STN:280:DC%2BD3M3gtlyntw%3D%3D Occurrence Handle11241307
SF Schoppmann P Birner P Studer S Breiteneder-Geleff (2001) ArticleTitleLymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer Anticancer Res 21 2351–2355 Occurrence Handle1:STN:280:DC%2BD3MnnvVShtw%3D%3D Occurrence Handle11724292
Y Cao P Linden J Farnebo R Cao A Eriksson V Kumar JH Qi L Claesson-Welsh K Alitalo (1998) ArticleTitleVascular endothelial growth factor C induces angiogenesis in vivo Proc Natl Acad Sci USA 95 14389–14394 Occurrence Handle10.1073/pnas.95.24.14389 Occurrence Handle1:CAS:528:DyaK1cXns1GlsL4%3D Occurrence Handle9826710
A Kaipainen J Korhonen T Mustonen VW Hinsbergh Particlevan GH Fang D Dumont M Breitman K Alitalo (1995) ArticleTitleExpression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development Proc Natl Acad Sci USA 92 3566–3570 Occurrence Handle1:CAS:528:DyaK2MXltFSmsLg%3D Occurrence Handle7724599
TA Partanen J Arola A Saaristo L Jussila A Ora M Miettinen SA Stacker MG Achen K Alitalo (2000) ArticleTitleVEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues Faseb J 14 2087–2096 Occurrence Handle10.1096/fj.99-1049com Occurrence Handle1:CAS:528:DC%2BD3MXhtF2rtLw%3D Occurrence Handle11023993
Y Nakamura H Yasuoka M Tsujimoto Q Yang A Tsukiyama S Imabun M Nakahara K Nakao M Nakamura I Mori K Kakudo (2003) ArticleTitleClinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up Mod Pathol 16 309–314 Occurrence Handle10.1097/01.MP.0000062858.98295.9F Occurrence Handle12692195
Y Nakamura H Yasuoka M Tsujimoto Q Yang S Imabun M Nakahara K Nakao M Nakamura I Mori K Kakudo (2003) ArticleTitleFlt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer Clin Cancer Res 9 5313–5317 Occurrence Handle1:CAS:528:DC%2BD3sXovVOnsr8%3D Occurrence Handle14614015
N Weidner JP Semple WR Welch J Folkman (1991) ArticleTitleTumor angiogenesis and metastasis – correlation in invasive breast carcinoma N Engl J Med 324 1–8 Occurrence Handle1:STN:280:DyaK3M%2FnsVWquw%3D%3D Occurrence Handle1701519 Occurrence Handle10.1056/NEJM199101033240101
S Heimburg MK Oehler T Papadopoulos H Caffier P Kristen J Dietl (1999) ArticleTitlePrognostic relevance of the endothelial marker CD 34 in ovarian cancer Anticancer Res 19 2527–2529 Occurrence Handle1:STN:280:DyaK1MzpvFWktg%3D%3D Occurrence Handle10470188
JS Goydos DH Gorski (2003) ArticleTitleVascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma Clin Cancer Res 9 5962–5967 Occurrence Handle1:CAS:528:DC%2BD3sXpsl2ls7Y%3D Occurrence Handle14676121
CA Heid J Stevens KJ Livak PM Williams (1996) ArticleTitleReal time quantitative PCR Genome Res 6 986–994 Occurrence Handle1:CAS:528:DyaK28XmsVWru7w%3D Occurrence Handle8908518
FA Tavassoli P Devilee (2003) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs IARC Press Lyon 10
HJ Bloom WW Richardson (1957) ArticleTitleHistological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years Br J Cancer 11 359–377 Occurrence Handle1:STN:280:DyaG1c%2Fkt1Gmtg%3D%3D Occurrence Handle13499785
MS Pepper (2001) ArticleTitleLymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 7 462–468 Occurrence Handle1:CAS:528:DC%2BD3MXjtVOgtbw%3D Occurrence Handle11297234
TA Partanen K Alitalo M Miettinen (1999) ArticleTitleLack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors Cancer 86 2406–2412 Occurrence Handle1:STN:280:DC%2BD3c%2FlvFGqtQ%3D%3D Occurrence Handle10590384
R Valtola P Salven P Heikkila J Taipale H Joensuu M Rehn T Pihlajaniemi H Weich R Waal Particlede K Alitalo (1999) ArticleTitleVEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer Am J Pathol 154 1381–1390 Occurrence Handle1:STN:280:DyaK1M3mtlektg%3D%3D Occurrence Handle10329591
AN Witmer BC Blijswijk Particlevan J Dai P Hofman TA Partanen GF Vrensen RO Schlingemann (2001) ArticleTitleVEGFR-3 in adult angiogenesis J Pathol 195 490–497 Occurrence Handle1:CAS:528:DC%2BD3MXovVGgt78%3D Occurrence Handle11745682
JK Ruohola EM Valve MJ Karkkainen V Joukov K Alitalo PL Harkonen (1999) ArticleTitleVascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells Mol Cell Endocrinol 149 29–40 Occurrence Handle1:CAS:528:DyaK1MXisFCrs7k%3D Occurrence Handle10375015
MJ Karkkainen P Haiko K Sainio J Partanen J Taipale TV Petrova M Jeltsch DG Jackson M Talikka H Rauvala C Betsholtz K Alitalo (2004) ArticleTitleVascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins Nat Immunol 5 74–80 Occurrence Handle1:CAS:528:DC%2BD3sXhtVWhtrzO Occurrence Handle14634646
MM Mattila JK Ruohola T Karpanen DG Jackson K Alitalo PL Harkonen (2002) ArticleTitleVEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors Int J Cancer 98 946–951 Occurrence Handle1:CAS:528:DC%2BD38Xis1Ohu78%3D Occurrence Handle11948478
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, Y., Yasuoka, H., Tsujimoto, M. et al. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 91, 125–132 (2005). https://doi.org/10.1007/s10549-004-5783-x
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-5783-x